Literature DB >> 28138624

Blood transfusion and postoperative complications: a cautionary comment.

Jian-Hong Zhong1, Bang-De Xiang1, Le-Qun Li1.   

Abstract

Year:  2016        PMID： 28138624      PMCID： PMC5244621          DOI： 10.21037/tgh.2016.06.09

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  10 in total

1.  Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.

Authors:  Tian Yang; Jun-Hua Lu; Wan Yee Lau; Tian-Yi Zhang; Han Zhang; Yi-Nan Shen; Kutaiba Alshebeeb; Meng-Chao Wu; Myron Schwartz; Feng Shen
Journal:  J Hepatol       Date:  2015-10-24       Impact factor: 25.083

2.  No impact of blood transfusion on oncological outcome after radical prostatectomy in patients with prostate cancer.

Authors:  K Boehm; B Beyer; P Tennstedt; J Schiffmann; L Budaeus; A Haese; M Graefen; T Schlomm; H Heinzer; G Salomon
Journal:  World J Urol       Date:  2014-07-03       Impact factor: 4.226

3.  Surgical outcomes and transfusion of minimal amounts of blood in the operating room.

Authors:  Victor A Ferraris; Daniel L Davenport; Sibu P Saha; Peter C Austin; Joseph B Zwischenberger
Journal:  Arch Surg       Date:  2012-01

4.  Intraoperative allogeneic red blood cell transfusion in ampullary cancer outcome after curative pancreatoduodenectomy: a clinical study and meta-analysis.

Authors:  Hou Shan Yao; Qiang Wang; Wei Jun Wang; Zhi Qian Hu
Journal:  World J Surg       Date:  2008-09       Impact factor: 3.352

5.  Perioperative blood transfusions do not impact overall and disease-free survival after curative rectal cancer resection: a propensity score analysis.

Authors:  Rene Warschkow; Ulrich Güller; Dieter Köberle; Sascha A Müller; Thomas Steffen; Martin Thurnheer; Bruno M Schmied; Ignazio Tarantino
Journal:  Ann Surg       Date:  2014-01       Impact factor: 12.969

6.  Allogeneic blood transfusion does not affect outcome after curative resection for advanced cholangiocarcinoma.

Authors:  Sascha A Müller; Arianeb Mehrabi; Nuh N Rahbari; Rene Warschkow; Heike Elbers; Christine Leowardi; Hamidreza Fonouni; Ignazio Tarantino; Peter Schemmer; Bruno M Schmied; Markus W Büchler
Journal:  Ann Surg Oncol       Date:  2013-08-28       Impact factor: 5.344

7.  Blood Transfusion in Major Abdominal Surgery for Malignant Tumors: A Trend Analysis Using the National Surgical Quality Improvement Program.

Authors:  Brett L Ecker; Kristina D Simmons; Salman Zaheer; Sarah-Lucy C Poe; Edmund K Bartlett; Jeffrey A Drebin; Douglas L Fraker; Rachel R Kelz; Robert E Roses; Giorgos C Karakousis
Journal:  JAMA Surg       Date:  2016-06-01       Impact factor: 14.766

Review 8.  Perioperative blood transfusions for the recurrence of colorectal cancer.

Authors:  A Amato; M Pescatori
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

9.  Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis.

Authors:  Lei Liu; Zhiwei Wang; Songqi Jiang; Bingfeng Shao; Jibing Liu; Suqing Zhang; Yilong Zhou; Yuan Zhou; Yixin Zhang
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

10.  Harms associated with single unit perioperative transfusion: retrospective population based analysis.

Authors:  Elizabeth L Whitlock; Helen Kim; Andrew D Auerbach
Journal:  BMJ       Date:  2015-06-12
  10 in total
  2 in total

1.  Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma.

Authors:  Wen-Feng Gong; Jian-Hong Zhong; Shi-Dong Lu; Xiao-Bo Wang; Qiu-Ming Zhang; Liang Ma; Zhi-Ming Zhang; Bang-De Xiang; Le-Qun Li
Journal:  Oncotarget       Date:  2017-02-28

2.  Perioperative entecavir for patients with HBV-related hepatocellular carcinoma and low levels of viral DNA: analysis using propensity score matching.

Authors:  Bao-Hong Yuan; Ru-Hong Li; Wei-Ping Yuan; Bang-De Xiang; Ming-Hua Zheng; Tian Yang; Jian-Hong Zhong; Le-Qun Li
Journal:  Oncotarget       Date:  2017-02-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.